Skip to content
DraconiticResearch
Search Sources API
190,860 studies31 sourcesUpdated 31 min ago
Peer-reviewedCC BYPharmaceutics

Saccharin-Enabled Oral Formulation, Biopharmaceutics and Early Genotoxicity Assessment of the PPARγ Antagonist T0070907

  • Charlotte Devant
  • François Xavier Legrand
  • Maria Eugenia Marques da Costa
  • Lilia Sehad
  • Nathalie Gaspar
  • Antonin Marchais
  • Maxime Annereau
  • Bernard Do
Read full textPDFDOICite

Related

  1. Advancing genotoxicity assessment with transcriptomic biomarkers: from 2D to 3D HepaRG spheroid models
    Mariam Saleh, Kevin Hogeveen, Anouck Thienpont +4
    Toxicological SciencesPeer-reviewedCC BY 4.0Full textGeneral biologyPharmacology & toxicologyHAL
  2. Predictive performance and farmer satisfaction of Jaɓnde, a digital decision-support tool for dairy-cow ration formulation: results from field assessment in Burkina Faso
    Songdah Désiré Ouattara, Ollo Sib, Mohamed Habibou Assouma +5
    Veterinary and Animal SciencePeer-reviewedCC BY 4.0Full textPlant biologyHAL
  3. Aquaporin-3 amplifies arsenite genotoxicity as a dose-dependent gene-by-environment interaction in human cells
    S. Yin, B. Feng, M. Vaziripour +5
    bioRxivPreprintCC BY-NC-NDFull text1 citedCell biologybioRxiv
  4. 5-HT1A Antagonist WAY-100635 Prevents Chronic Neurodegeneration and Immune Activation After TBI
    A. Das, S. Dutta, L. K. Pradhan +3
    bioRxivPreprintAll rights reservedFull textNeurosciencebioRxiv
  5. Structural mechanism of TRPC3 inhibition by a potent antagonist
    Jodie Collingridge, Bethan A. Cole, Molly A. Rowlett +4
    Journal of Biological ChemistryPeer-reviewedCC BY 4.0NeuroscienceCrossref

Cite

BibTeXRIS
BibTeX
@article{devant2026saccharinenabled,
  title = {{Saccharin-Enabled Oral Formulation, Biopharmaceutics and Early Genotoxicity Assessment of the PPARγ Antagonist T0070907}},
  author = {Charlotte Devant and François Xavier Legrand and Maria Eugenia Marques da Costa and Lilia Sehad and Nathalie Gaspar and Antonin Marchais and Maxime Annereau and Bernard Do},
  journal = {Pharmaceutics},
  year = {2026},
  month = oct,
  doi = {10.3390/pharmaceutics18101258},
  url = {https://hal.science/hal-05785231v1},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Saccharin-Enabled Oral Formulation, Biopharmaceutics and Early Genotoxicity Assessment of the PPARγ Antagonist T0070907
AU  - Charlotte Devant
AU  - François Xavier Legrand
AU  - Maria Eugenia Marques da Costa
AU  - Lilia Sehad
AU  - Nathalie Gaspar
AU  - Antonin Marchais
AU  - Maxime Annereau
AU  - Bernard Do
PY  - 2026
DA  - 2026/10/01
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics18101258
UR  - https://hal.science/hal-05785231v1
SN  - 1999-4923
ER  -